Predictive value of preoperative albumin-bilirubin score and other risk factors for short-term outcomes after open pancreatoduodenectomy

Table 5 Factors associated with reoperation (univariate logistic regression), n (%)

	No reoperation (n = 273)	Reoperation (n = 74)	OR (95%CI)	P value
Male gender	143 (52.4)	50 (67.6)	1.89 (1.10-3.26)	0.021
Age (yr), median (IQR)	68 (61-75)	70.5 (63-76)	1.02 (0.99-1.04)	0.192
BMI, median (IQR)	24.9 (22.4-27.9)	26.1 (22.8-30.1)	1.07 (1.01-1.14)	0.018
ASA score
1	9 (3.3)	1 (1.4)	1
2	108 (39.6)	28 (37.8)	2.33 (0.28-19.2)	0.431
3	155 (56.8)	42 (56.8)	2.44 (0.30-19.79)	0.404
4	1 (0.4)	3 (4.1)	27 (1.26-578.35)	0.035
ALBI score	-2.6 (-3.0 to -2.0)	-2.7 (-3.0 to -1.7)	1.27 (0.87-1.85)	0.211
Operation type
PPPD	144 (52.7)	31 (41.9)	1
Whipple	129 (47.3)	43 (58.1)	1.55 (0.92-2.60)	0.099
Somatostatin use	142 (52)	43 (58.1)	1.28 (0.76-2.15)	0.352
Soft pancreatic texture	114 (47.5)	50 (74.6)	3.25 (1.77-5.96)	< 0.001
Blood loss (mL), median (IQR)	400 (250-500)	400 (300-800)	1.07 (1.02-1.13)	0.007
Pathology
Pancreatic carcinoma	144 (52.7)	26 (35.1)	0.49 (0.28-0.83)	0.008
Bile duct carcinoma	28 (10.3)	8 (10.8)	1.06 (0.46-2.44)	0.890
Duodenal carcinoma	3 (1.1)	6 (8.1)	7.94 (1.94-32.57)	0.004
Ampullary carcinoma	36 (13.2)	10 (13.5)	1.03 (0.48-2.18)	0.941
NET	20 (7.3)	7 (9.5)	1.32 (0.54-3.26)	0.544
IPMN	11 (4.0)	5 (6.8)	1.73 (0.58-5.13)	0.326

OR: Odds ratio; IQR: Interquartile range; BMI: Body mass index; ALBI: Albumin-bilirubin; ASA score: American Society of Anesthesiologists score; PPPD: Pylorus-preserving pancreatoduodenectomy; NET: Neuroendocrine tumour; IPMN: Intraductal papillary mucinous neoplasm.